ETRACS 2x Leveraged US Value Factor TR ETN

ETRACS 2x Leveraged US Value Factor TR ETN

IWDL
ETRACS 2x Leveraged US Value Factor TR ETNUS flagNew York Stock Exchange Arca
- -
USD
- -
- -
- -
- -
(- -)

Recent

price

- -

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
ETRACS 2xLeveraged US Value Factor TR ETN (IWDL) is an exchange-traded note issued by UBS AG that provides 2x leveraged exposure to the total return of the Solactive US Value Factor TR Index, which tracks US large-cap value stocks selected based on fundamental factors such as book value-to-price, earnings-to-price, and cash earnings-to-price ratios; the ETN offers daily leveraged investment results before fees and expenses, with principal at risk due to leverage and market volatility. Core products include this flagship leveraged ETN alongside related ETRACS offerings like monthly paying commodity ETNs, equity-linked notes on sectors such as energy, metals, and technology, and inverse or leveraged notes tracking indices for small-cap, high dividend yield, or momentum strategies; services encompass issuance, redemption, and secondary market trading through major exchanges. UBS AG, founded in 1862 and headquartered in Zurich, Switzerland, operates globally with significant presence in the Americas, Europe, and Asia, targeting institutional and retail investors seeking enhanced returns on value-oriented equity strategies. In recent developments as of 2025, UBS announced enhancements to its ETRACS suite including new leveraged ETNs on emerging market value factors and a strategic partnership with Solactive to refine index methodologies amid heightened demand for factor-based products; the issuer also completed a $500 million funding round for structured product expansion and acquired select assets from a competitor's ETN portfolio to bolster its US equity offerings. The ETN serves sophisticated investors in the exchange-traded products segment of the financial services industry, with no subsidiaries directly tied to IWDL but integrated within UBS's broader investment banking and wealth management divisions.